An Open, Phase two trial of the efficacy and safety of ISIS 2503 in women with metastatic breast cancer.

Project: Industry

Participants

Colleges, School and Institutes

Short titleAn Open, Phase two trial of the efficacy and safety of ISIS 2503 in women with metastatic breast cancer.
StatusFinished
Effective start/end date1/11/0031/10/02